Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Material Contracts

VivoSim Labs, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-07-17: Form 8-K; Exhibit 10.2; Description Placement Agency Agreement, dated July 16, 2026, between the Company and A.G.P./Alliance Global Partners..
  • 2026-07-17: Form 8-K; Exhibit 10.1; Description Securities Purchase Agreement, dated July 16, 2026, between the Company and the purchaser identified on the signature page thereto..
  • 2026-07-14: Form 10-K; Exhibit 10.33; Description Offer Letter, dated November 18, 2025, between the Company and Amar Sethi..
  • 2025-08-14: Form 8-K; Exhibit 10.1; Description Offer Letter, dated July 25, 2025, between VivoSim Labs, Inc. and Tony Lialin..
FiledFormExhibitDescription
2026-07-178-K10.2Placement Agency Agreement, dated July 16, 2026, between the Company and A.G.P./Alliance Global Partners.
2026-07-178-K10.1Securities Purchase Agreement, dated July 16, 2026, between the Company and the purchaser identified on the signature page thereto.
2026-07-1410-K10.33Offer Letter, dated November 18, 2025, between the Company and Amar Sethi.

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70